Investment Q&A

Q: Can I get your thoughts on the valuation of the healthcare industry? Could you provide a few picks on dividend paying healthcare stocks?

Thanks,

Joe

Q: I would like your view on ZUT please.

Q: Hi Peter
for a TFSA account, would Bep.un be preferred to Bep.ca ?
I am going to start a partial position

In a RRSP account, which one would you prefer ?
I got some shares of Bepc from a spin out from the Bep.un in the RRSp
should I leave it as it is or which one do you prefer; if a switch is needed for
long term hold

thanks
I am retired

Michael

Q: Hi 5i team,
Rogers and Altice are back again with a higher offer for CGO and CCA. The Audet family, who hold the controlling interests, have rejected it again and have stated that this is not a negotiating ploy. The revised offer will be submitted to the Boards of CCA and CGO. What in your view typically happens in hostile bids with a controlling shareholder? Does the controlling shareholder really control how these events unfold or do the minority shareholders start applying pressure to start negotiating and then it becomes merely a matter of price?
Thanks for the insight.
Dave

Q: Could you please compare these two.
Which one you prefer today?

Thanks,
Milan

Q: Have you got an updated opinion on IPGP? I am looking at taking a half position then adding on a pullback.

Q: Hi guys,
RE: FNGS .. MicroSectors FANG+ ETN
I came across this while researching tech ETF's.
This is the description on the RBC Direct Investing website.
The investment seeks to link the return to the performance of the gross total return version of the NYSE® FANG+™ Index. The index is an equal-dollar weighted index designed to represent a segment of the technology and consumer discretionary sectors consisting of highly-traded growth stocks of technology and tech-enabled companies. The notes are unsecured and unsubordinated obligations of Bank of Montreal. Each note will have an initial principal amount of $50.
BMO Investorline does not have it in their menu.
Please give me your insights and opinion on this product.
Thanks as always,
Steve

Q: Can you please explain what this means & why it is impacting the price? Thanks!
Vaxart (NASDAQ:VXRT) is down 6% premarket on increased volume. Shares have sold off over 20% since last week after it disclosed a $250M at-the-market stock sales deal with Jefferies.

Q: I am more growth oriented and fairly aggressive in my portfolios. I currently own Loblaw but I am thinking of switching to Maple Leaf Foods or PBH because I think they will grow more.
What is 5I’s view on these two companies and making a switch

Thank You

Q: My wife and I are 80 years old and we live off the dividends from our RRIF's which are totally invested in stocks as well as the CPP.
Looking ahead my wife who has not been involved in the stock market would have a difficult time managing on her own. With this in mind I am contemplating going from stocks for some or all and switching to ETF's covering the different market segments making a passive portfolio that would require little maintenance . Appreciate your thoughts on this strategy and what would be your favourite ETF's by market segment. Looking for approx 4% or higher dividend with little or moderate growth.
Regards

D

Q: CSU.DB:CA : fell almost 5% this morning, albeit on low volume. trivial . Such a drop is extremely unusual for this security. I do not follow Canadian markets and am wondering if this price drop is consistent with price changes in other similar interest sensitive securities this morning. Are you aware of any reason for such a drop? (I am restricted from CSU and SHOP common but have a large position in the debentures)

Q: Would you be comfortable with a new position in REAL today? Any reason to look for new opportunites elsewhere outside of real?

Q: good morning - further to a question last week about trading within a TFSA and limiting the number of trades to keep below CRA radar I am unclear on what constitutes a "trade". Is it buying and selling the same stock or does every purchase and every sale ( whether the same company or not) constitute a trade. Thanks

Q: Hello Peter & Team,

We're all aware over the past 9 months since the Pandemic became part of our every day life, on-line shopping has really taken off.

I am thinking Cyber Security is going to have to follow suit considering how much money is travelling through the internet. Do you agree this industry should see a considerable increase in opportunities & growth in the coming years? And if so, which companies would you suggest we take a look at if we want exposure to cyber security.

Thanks for all you do.

gm

Q: Neo has been doing very well as of late.What are your thoughts about this company and fundamental views.
Is the rise warranted in your view and would you step in here.
You have better alternatives?

Q: With the recent action taken by the FDA in amending theIr existing emergency use authorisation to include hologic's PANTHER system FOR COVID-19 tests which I understand provides virtually instant results with 100% ACCURACY. !!!!
please rate/Update your opinion of hOLX as a long term investment now ?
John

Q: intrigued by the volume and increase in price over the last week! do you still believe this is directly related to the last quarter figures or possibly some sort of M & A activity?
ed in Montreal

Q: With all these lawsuits, tariffs and inquisitions going on these companies due to their overall dominance / killing competition etc..How much is it affecting their ability to conduct business.. or the costs are so small, it is just a cost of doing business for these companies? Is it really impacting their revenues, profits etc..I can see it affects their ability to buy new businesses.. Thanks. Regards, Shyam

Q: Good afternoon, Do you see any value in continuing to own TWM - I am down around 10%. Analyst ratings are a "strong buy".

Q: I'm looking for some ideas on how to strengthen my healthcare holdings, which only account for 5% of my portfolio. I have a full position in NVO, half positions in CSH.UN and SIS, and have just started to build a position in the PSCH small cap health care fund. GUD and COV are technically present, but both are losers and small enough to ignore/sell.

Q#1: What additions/changes would you suggest for a retired person who is in pretty solid financial shape (5 year holding horizon, can tolerate some risk, but not aiming to shoot out the lights)?

Q#2: What percentage of the total portfolio would you aim to put in healthcare these days? It seems like there are a lot of developments in this field.